The atropine factor in pharmacologic stress echocardiography
- 1 April 1996
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 27 (5), 1164-1170
- https://doi.org/10.1016/0735-1097(95)00586-2
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Comparison of the diagnostic potential of four echocardiographic stress tests shortly after acute myocardial infarction: submaximal exercise, transesophageal atrial pacing, dipyridamole, and dobutamine-atropineThe American Journal of Cardiology, 1996
- Stress echocardiography for diagnosis of coronary artery diseaseJournal of the American College of Cardiology, 1996
- Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery diseaseThe American Journal of Cardiology, 1994
- Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery diseaseThe American Journal of Cardiology, 1993
- Echocardiography and coronary artery diseaseThe International Journal of Cardiovascular Imaging, 1993
- Effect of beta-adrenoceptor blockade on dipyridamole-induced myocardial asynergies in coronary artery diseaseThe American Journal of Cardiology, 1992
- Should antianginal medication be stopped for exercise testing?The Lancet, 1992
- Safety of intravenous high-dose dipyridamole echocardiographyThe American Journal of Cardiology, 1992
- Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiographyThe American Journal of Cardiology, 1992
- Different degrees of ischemic threshold stratified by the dipyridamole-echocardiography testThe American Journal of Cardiology, 1987